Your browser doesn't support javascript.
loading
A phase I trial of the CDK 4/6 inhibitor palbociclib in pediatric patients with progressive brain tumors: A Pediatric Brain Tumor Consortium study (PBTC-042).
Van Mater, David; Gururangan, Sridharan; Becher, Oren; Campagne, Olivia; Leary, Sarah; Phillips, Joanna J; Huang, Jie; Lin, Tong; Poussaint, Tina Young; Goldman, Stewart; Baxter, Patricia; Dhall, Girish; Robinson, Giles; DeWire-Schottmiller, Mariko; Hwang, Eugene I; Stewart, Clinton F; Onar-Thomas, Arzu; Dunkel, Ira J; Fouladi, Maryam.
Afiliación
  • Van Mater D; Division of Pediatric Hematology-Oncology, Department of Pediatrics, Duke University Medical Center, Durham, North Carolina.
  • Gururangan S; Preston A. Wells Center for Brain Tumor Therapy, Department of Neurosurgery, McKnight Brain Institute, University of Florida, Gainesville, Florida.
  • Becher O; Department of Pediatrics, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.
  • Campagne O; Pharmaceutical Sciences Department, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Leary S; Division of Pediatrics, Seattle Children's Hospital, Seattle, Washington.
  • Phillips JJ; Departments of Neurological Surgery and Pathology, University of California San Francisco, San Francisco, California.
  • Huang J; Department of Biostatistics, St Jude Children's Hospital, Memphis, Tennessee.
  • Lin T; Department of Biostatistics, St Jude Children's Hospital, Memphis, Tennessee.
  • Poussaint TY; Department of Radiology, Boston Children's Hospital, Boston, Massachusetts.
  • Goldman S; Department of Pediatrics, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.
  • Baxter P; Department of Pediatrics, Texas Children's Hospital, Houston, Texas.
  • Dhall G; Division of Hematology and Oncology, Children's of Alabama, Birmingham, Alabama.
  • Robinson G; Division of Neuro-Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • DeWire-Schottmiller M; Department of Pediatrics, Cincinnati Children's Hospital, Cincinnati, Ohio.
  • Hwang EI; Children's National Medical Center, Washington, District of Columbia.
  • Stewart CF; Pharmaceutical Sciences Department, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Onar-Thomas A; Department of Biostatistics, St Jude Children's Hospital, Memphis, Tennessee.
  • Dunkel IJ; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Fouladi M; Department of Pediatrics, Cincinnati Children's Hospital, Cincinnati, Ohio.
Pediatr Blood Cancer ; 68(4): e28879, 2021 04.
Article en En | MEDLINE | ID: mdl-33405376
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Piperazinas / Piridinas / Neoplasias Encefálicas / Inhibidores de Proteínas Quinasas / Antineoplásicos Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: Pediatr Blood Cancer Asunto de la revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Piperazinas / Piridinas / Neoplasias Encefálicas / Inhibidores de Proteínas Quinasas / Antineoplásicos Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: Pediatr Blood Cancer Asunto de la revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Año: 2021 Tipo del documento: Article